Nanomedicine Strategies to Ameliorate Neuroinflammation and Prevent Secondary Neural Tissue Damage
ACS Nano Medicine · 11.11.2026 · 1 (10) · 2519-2539
DOI: 10.1021/acsnanomed.6c00120 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 11.08.2026. Verfasst von Rachel A. Aguillard und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 156 Literaturangaben. Gefördert von: Cockrell School of Engineering, University of Texas at Austin, University of Texas at Austin, Philanthropic Educational Organization.
Abstract (Originalsprache)
The burden of neurological disease remains a global issue, continually rising, requiring the need for effective therapeutics to disrupt disease progression. Across neurological diseases, neuroinflammation presents as a shared pathophysiological hallmark, presenting a compelling therapeutic target for restoring tissue homeostasis and preventing further tissue damage. Yet, early interventions of neuroinflammation require multifaceted design of central nervous system (CNS) delivery systems that overcome the cascade of biological barriers and effectively target the inflamed tissue. We explore the role of CNS delivery in treating neuroinflammation in the CNS tissue caused by different insults (pathogens, mechanical force, and dysregulated immune attack) in three exemplary disease states of CNS infections, traumatic brain injury (TBI), and multiple sclerosis (MS). Additionally, we examine the critical design requirements of the CNS delivery system to overcome the different biological barriers to reach the inflamed neural tissue in context of the pathophysiology of neuroinflammation. Moreover, we highlight the emerging nanomedicines that present promising advances to disrupt neuroinflammation and restore the neural tissue in the context of CNS infections, TBI, and MS. Our analysis illustrates the continual critical need for multifaceted design of CNS delivery systems in the context of the pathophysiology of the source of insult to neural tissue inflammation to improve therapeutic outcomes. Moving forward, the field needs to push forward a multifaceted, systematic design of delivery systems that considers less invasive administrative routes and integrates detection with treatment to ultimately provide nanomedicine for successful interventions of neurological diseases.
Förderung
- Cockrell School of Engineering, University of Texas at Austin
- University of Texas at Austin
- Philanthropic Educational Organization
- Lyda Hill Philanthropies
- Funda??o para a Ci?ncia e a Tecnologia
Zitieren
APA
Aguillard, R. A., & Peppas, N. A. (2026). Nanomedicine Strategies to Ameliorate Neuroinflammation and Prevent Secondary Neural Tissue Damage. ACS Nano Medicine, 1(10), 2519-2539. https://doi.org/10.1021/acsnanomed.6c00120
Vancouver
Aguillard RA, Peppas NA. Nanomedicine Strategies to Ameliorate Neuroinflammation and Prevent Secondary Neural Tissue Damage. ACS Nano Medicine. 2026;1(10):2519-2539. doi:10.1021/acsnanomed.6c00120
BibTeX
@article{Aguillard2026,
author = {Aguillard, Rachel A. and Peppas, Nicholas A.},
title = {Nanomedicine Strategies to Ameliorate Neuroinflammation and Prevent Secondary Neural Tissue Damage},
journal = {ACS Nano Medicine},
year = {2026},
volume = {1},
number = {10},
pages = {2519--2539},
doi = {10.1021/acsnanomed.6c00120}
}
EUVIMED